Therapy Market Research Reports & Industry Analysis
Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
... pembrolizumab (Keytruda). RESEARCH METHODOLOGY The market study of global oncolytic virus therapy market is incorporated by extensive primary ... global oncolytic virus therapy market. Insights about market determinants which are stimulating the global oncolytic virus therapy market. Detailed and extensive market ...
Dec, 2018Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market SUMMARY Non-alcoholic steatohepatitis (NASH) is the severe form of non ...
Dec, 2018 112 pagesAtopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies SUMMARY Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from ...
Nov, 2018 113 pages... of global oncolytic virus therapy market are lack of awareness among users and new class of anticancer immunotherapy. Oncolytic virus therapy is a virus that ... period – 2018 to 2025 Target Audience of the Global Oncolytic Virus Therapy Market in Market Study: Key Consulting Companies & Advisors Large, medium ...
Dec, 2018 200 pages... – 2018 to 2025 Target Audience of the Global CNS Therapeutics Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
Dec, 2018 200 pages... clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company ...
Oct, 2018 206 pages... Adrenal Insufficiency) Global Clinical Trials Review, H2, 2018 SUMMARY GlobalData's clinical trial report, “Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H2, 2018' provides an overview of Addison's Disease (Primary or Chronic Adrenal Insufficiency) clinical trials ...
Oct, 2018 55 pagesEpilepsy Therapeutics in Asia-Pacific Markets to 2024 - Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth SUMMARY Epilepsy is a chronic disorder of the brain with substantial morbidity ...
Nov, 2018 120 pages... Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies CAR-T Cell Therapies in Highest Phase: Preclinical Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) Global Market Scenario of CAR T Cell Therapy Global CAR T Cell Therapy Market Future Prospects The research in immunotherapy ...
Nov, 2018 400 pages... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
Oct, 2018 51 pages... drug stability, which boost its demand in the market. The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and ... 6.9% from 2018 to 2025. The factors that propel the PEGylated protein therapeutics market growth include high prevalence of chronic diseases, such as cancer ...
Aug, 2018 166 pages... the players operating in this market. The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes ...
Sep, 2018 225 pagesStem Cell Therapies in Neurology SUMMARY 'Stem Cell Therapies in Neurology', is an evolving field. The current pipeline of products feature different types of stem cells and these therapies have the potential to target a range of neurological diseases. However ...
Sep, 2018 67 pagesKOL Perspectives: Mid-to-Late Stage Pipeline Therapies in Lupus SUMMARY This KOL Insight briefing focuses on opinions of mid%li%to late-stage pipeline therapies in lupus. The briefing includes analysis of KOL opinion on the following topic areas - Development of Lupuzor for ...
Feb, 2018 39 pagesHeart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy SUMMARY Heart failure ... hypertension. HF has been gradually rising in the Asia-Pacific ... therapy, ACE inhibitors, ATR blockers, If channel inhibitor, beta ...
Sep, 2018 123 pages... . It also explains complete structure of reimbursement policies. Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies is the 15th report published by Renub Research on Proton Therapy Market. This 238 page report with ...
Oct, 2018... , Inc., and Others. This report segments the global Parkinsons disease therapeutics market as follows: Global Parkinsons Disease Therapeutics Market: Drug Class Segment Analysis Levodopa Combination Dopamine Agonists ...
May, 2018 110 pages... segments the global monoclonal antibody therapeutics market as follows: Global Monoclonal Antibody Therapeutics Market: Application Segment Analysis Cancer Autoimmune Diseases Infection Hematological Diseases Others Global Monoclonal Antibody Therapeutics Market: Source Segment ...
Apr, 2018 110 pagesThe global women’s health therapeutics market size is expected to reach USD 210.9 billion by 2025, according to a new ... commercialization and approval of products, and investment by market players Some of the key players in women’s health therapeutics market are Bayer AG, Merck & Co., Pfizer, Teva ...
Jul, 2018 140 pages... HER2 MESO EGFRvII Others Regional CAR-T Cell Therapy Market & Forecast North America Europe Asia Pacific Latin America Middle East Africa Global – CAR T Cell Therapy Clinical Trials/Study CD19 CD20 GD2 ...
Aug, 2018... damage, and urinary tract infections (UTIs). The global benign prostatic hyperplasia therapeutics market was valued at $10,688.72 million in 2017, ... global benign prostatic hyperplasia therapeutics market is segmented into therapeutic class, therapy, and region. On the basis of therapeutic class, the market is ...
Jul, 2018 205 pagesAsian Cryotherapy Units Market to reach USD XXX billion by 2025. Asian Cryotherapy Units Market valued approximately USD XXX billion in 2016 is ... Target Audience of the Asian Cryotherapy Units Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture ...
Aug, 2018 120 pages... is 2017, and the market size is projected from 2018 to 2023. The global market for peptide therapeutics has been witnessing a substantial rise in its ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 157 pages... study is 2017, and the market size is projected from 2018 to 2023. A range of hyperbaric oxygen chambers of various designs and sizes combined with increasing ... the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 154 pages... the market size is projected from 2018 to 2023. Over the past few years, the demand for biotherapeutics has witnessed a significant rise, thanks ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 153 pages... the study is 2017, and the market size is projected from 2018 to 2023. Autologous cell therapy refers to infusion or transfer of human tissue or cells back ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 195 pagesOsteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness SUMMARY Osteoporosis is a “silent epidemic” and ...
Jul, 2018 138 pagesGene Therapy in CVMD SUMMARY Gene therapies have been a point of ... the pipeline, clinical, and commercial landscape of gene therapies in CVMD supplemented with a variety of KOL and payer perspectives ... the trends shaping and driving the global CVMD gene therapy market. Drive revenues by understanding the ...
Jun, 2018 80 pages... 31 data tables and 41 additional tables An overview of global market for current research & developments status of Chimeric Antigen Receptor (CAR) T-cell therapy Analyses of global market trends, with data from 2017, estimates for ...
Jul, 2018 273 pagesCompetitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway ... . In addition, the report lists company-specific R&D pipelines of modulators of the tumor microenvironment. Competitor projects are listed in a tabular format providing information on: Drug ...
Jul, 2018 204 pagesCompetitor Analysis: CTLA-4, LAG-3, TIM-3, TIGIT & Other Immune Checkpoint Inhibitors 2018 This Competitive Intelligence report analyzes the competitive field of CTLA-4, LAG-3, TIM-3, TIGIT & Other Immune Checkpoint Inhibitors ...
Jun, 2018 84 pagesCompetitor Analysis: CD40, GITR, OX40, 4-1BB, CD27, ICOS & Other Immune Checkpoint Activators 2018 This Competitive Intelligence report analyzes the competitive field of CD40, GITR, OX40, 4-1BB, CD27, ICOS ...
Jul, 2018 78 pages... releases. The Barth Syndrome (Other Diseases) pipeline guide also reviews of key players involved in therapeutic development for Barth Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Jul, 2018 42 pages... is the 6th edition report on Proton Therapy Market by iGATE RESEARCH. The report titled “Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment ...
Jul, 2018 429 pagesHigh-intensity focused ultrasound (HIFU) is a precise medical procedure, which applies high-intensity focused ultrasound energy to locally heat and destroy damaged or diseased tissue through ablation. In this therapy, ultrasound beams are focused on diseased ...
Jun, 2018 135 pagesThe global gene therapy market size is expected to reach USD 39.54 million by 2026. Rising competition among manufacturers ... better efficacy as compared to gene therapy alone. Cancer held the dominant share in the market in 2017 owing to relatively high adoption of gene therapies for cancer treatment. Continual ...
May, 2018 120 pagesPsoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market SUMMARY Psoriasis is a common, chronic inflammatory skin ... people with psoriasis eventually develop psoriatic arthritis. Psoriasis is a serious skin condition that has ...
Jun, 2018 125 pages... less successful against solid tumors. This report „TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & ... acquisition prices and financing rounds. Download Sample Pages: TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders ...
May, 2018 294 pagesGlobal Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves ...
Mar, 2018 99 pagesHAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies SUMMARY Hereditary Angioedema (HAE) is a rare genetic disorder ... fluids to build up in body tissues (edema). The onset of HAE may occur at any age but is ...
Mar, 2018 92 pages... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Apr, 2018 529 pages... potential. Kuick Research Report on the Global cell therapy market provides a detailed insight into the current scenario of the cell therapy market worldwide. Key data like pricing of cell therapy products, cost analysis of cell therapy ...
Apr, 2018 1200 pagesMicrobiome-Targeted Therapeutics in Immunology SUMMARY Flares in gastrointestinal and dermatology indications are characterized by a shift in the proportion of bacterial species in either the gut or skin microbiome ... shaping and driving the global microbiome market in immunology. Formulate effective sales and ...
Mar, 2018 78 pages... past four years, Lion’s Mane Mushroom Extract market size to maintain the average annual growth rate ... the world, which shows a regional development status, including market size, volume and value, as well as price data ... , channel segment etc. cover different segment market size, both volume and value. Also cover ...
Oct, 2018 119 pages... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) development landscape Develop and design in-licensing and ...
Apr, 2018 51 pages... for these patients. In this report we discuss the recently approved therapies for CMV infections, other drugs and vaccines in the pipeline ...
Apr, 2018 42 pagesRheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs SUMMARY Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...
Mar, 2018 148 pages... the past four years, Instant Whipping Agents market size to maintain the average annual growth rate ... the world, which shows a regional development status, including market size, volume and value, as well as price data ... , channel segment etc. cover different segment market size, both volume and value. Also cover ...
Oct, 2018 116 pages... in-depth analysis of the global cell therapy processing market by offering type, application and geographic regional markets. The report includes key inhibitors ... in the global cell therapy processing market. In-depth patent analysis in the report will provide extensive technological trends across years ...
Mar, 2018 187 pages